An unusual earnings report that revealed its usually predictable and profitable Biological Indicators division had underperformed, resulted in Mesa Laboratories (NASDAQ:MLAB) taking a big hit over a three-day period, dropping from $67.33 on August 6, 2013 to $58.79 on the close of trading on August 9, 2013.
As the anomaly was understood by investors, the share price started to rebound, already soaring almost 5% on Monday, August 12, 2013, to close at $61.63 per share. Having dropped just under 14%, there is still a lot of upside in the near term, and over the long term will continue on its upward run.
With the incident leading to the miss in the latest quarter having already been taken care...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|